Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection

Memórias do Instituto Oswaldo Cruz

Christopher S Eickhoff¹  Olivia K Giddings¹  Nobuko Yoshida¹  Daniel F Hoft² 

[1] ,Saint Louis University Department of Molecular Microbiology ,USA

关键词: Trypanosoma cruzi;    mucosal immunity;    vaccines;   

DOI  :  10.1590/S0074-02762010000500015

来源: SciELO

【 摘 要 】

The potential use of the Trypanosoma cruzi metacyclic trypomastigote (MT) stage-specific molecule glycoprotein-82 (gp82) as a vaccine target has not been fully explored. We show that the opsonization of T. cruzi MT with gp82-specific antibody prior to mucosal challenge significantly reduces parasite infectivity. In addition, we investigated the immune responses as well as the systemic and mucosal protective immunity induced by intranasal CpG-adjuvanted gp82 vaccination. Spleen cells from mice immunized with CpG-gp82 proliferated and secreted IFN-γ in a dose-dependent manner in response to in vitro stimulation with gp82 and parasite lysate. More importantly, these CpG-gp82-immunized mice were significantly protected from a biologically relevant oral parasite challenge.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License